Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Getting Physical on Cigarettes: Exercise and Smoking Cessation - Preventing Relapse
Brief Summary: Adult female smokers will participate in an exercise-aided smoking cessation program, and will then be randomized into one of four cessation maintenance conditions: (a) Exercise Maintenance only (b) Exercise Maintenance + Relapse Prevention Booklets(c) Relapse Prevention Booklets + Contact and (d) Contact Control. Primary follow-up outcome is smoking behaviour. Secondary outcomes include exercise behaviour, Physiological measures (body composition (Dual-emission X-ray absorptiometry; DXA), vascular health (stiffness, endothelial function, carotid plaque volume), physical fitness), and Psychological measures (self-regulatory cognitions related to exercise adherence \[exercise, scheduling, barrier, relapse, and concurrent self-regulatory self-efficacy\]).

The hypotheses detailed below are specific to the randomization of participants into the following 4 groups:

1. Exercise Maintenance only
2. Exercise Maintenance + Relapse Prevention Booklets
3. Relapse Prevention Booklets + Contact
4. Contact Control

Hypothesis 1: Compared to quitters in the contact control condition, quitters exposed to a home-based lifestyle exercise maintenance intervention (Exercise Maintenance only and Exercise Maintenance + Relapse Prevention Booklets) will demonstrate significantly greater exercise adherence and fitness levels, as well as significantly less weight gain and smoking relapse rates following exercise-aided smoking cessation program termination.

Hypothesis 2: Compared to quitters in the contact control condition, quitters exposed to relapse information only (Relapse Prevention Booklets + Contact) will experience significantly less smoking relapse following exercise-aided smoking cessation program termination.

Due to the novelty and exploratory nature of the respective prevention programs, no hypotheses are specified with respect to which prevention program (exercise maintenance or relapse prevention information) will be superior to the other, or whether the additive benefits (i.e., exercise maintenance plus relapse prevention information) will be superior to one prevention program alone.


Options:
A: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise and counseling (for smoking cessation and physical activity) | Arm Label: physical activity program; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise and counseling (for smoking cessation and physical activity) | Intervention Type: BEHAVIORAL; Name: Exercise and counseling (for smoking cessation and physical activity); Assigned to Arm(s): Control, physical activity program
B: Arm Label: Exercise Maintenance; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise Behaviour Maintenance | Arm Label: Ex. Maintenance + relapse prevention; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise Behaviour Maintenance, Behavioral: Smoking Relapse prevention booklets | Arm Label: relapse prevention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Smoking Relapse prevention booklets | Arm Label: Contact Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Contact control | Intervention Type: BEHAVIORAL; Name: Exercise Behaviour Maintenance; Assigned to Arm(s): Ex. Maintenance + relapse prevention, Exercise Maintenance | Intervention Type: BEHAVIORAL; Name: Smoking Relapse prevention booklets; Assigned to Arm(s): Ex. Maintenance + relapse prevention, relapse prevention | Intervention Type: BEHAVIORAL; Name: Contact control; Assigned to Arm(s): Contact Control
C: Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: varenicline; Type: ACTIVE_COMPARATOR; Interventions: Drug: varenicline tartrate | Arm Label: bupropion; Type: ACTIVE_COMPARATOR; Interventions: Drug: bupropion hydrochloride | Arm Label: Nicotine Replacement Therapy Patch; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nicotine Replacement Therapy Patch | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo | Intervention Type: DRUG; Name: varenicline tartrate; Assigned to Arm(s): varenicline | Intervention Type: DRUG; Name: bupropion hydrochloride; Assigned to Arm(s): bupropion | Intervention Type: DRUG; Name: Nicotine Replacement Therapy Patch; Assigned to Arm(s): Nicotine Replacement Therapy Patch
D: Arm Label: Nicotine E-Cigarette and Counseling; Type: EXPERIMENTAL; Interventions: Other: Nicotine E-Cigarette, Behavioral: Counseling | Arm Label: Non-Nicotine E-Cigarette and Counseling; Type: OTHER; Interventions: Other: Non-Nicotine E-Cigarette, Behavioral: Counseling | Arm Label: Counseling; Type: OTHER; Interventions: Behavioral: Counseling | Intervention Type: OTHER; Name: Nicotine E-Cigarette; Assigned to Arm(s): Nicotine E-Cigarette and Counseling | Intervention Type: OTHER; Name: Non-Nicotine E-Cigarette; Assigned to Arm(s): Non-Nicotine E-Cigarette and Counseling | Intervention Type: BEHAVIORAL; Name: Counseling; Assigned to Arm(s): Counseling, Nicotine E-Cigarette and Counseling, Non-Nicotine E-Cigarette and Counseling

Answer: B